Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYSB2400130	注射用阿替普酶	alteplase	Lyophilized	Biological Products	Supplementary Application	2024-06-21		Boehringer Ingelheim Pharma Gmbh & Co KG			view
JYSB2400129	注射用阿替普酶	alteplase	Lyophilized	Biological Products	Supplementary Application	2024-06-21		Boehringer Ingelheim Pharma Gmbh & Co KG			view
JYSB2400028	注射用阿替普酶	alteplase	Lyophilized	Biological Products	Supplementary Application	2024-02-06		Boehringer Ingelheim Pharma Gmbh & Co KG			view
JYSB2400029	注射用阿替普酶	alteplase	Lyophilized	Biological Products	Supplementary Application	2024-02-06		Boehringer Ingelheim Pharma Gmbh & Co KG			view
JYSB2300167	注射用阿替普酶	alteplase	Lyophilized	Biological Products	Supplementary Application	2023-09-20		Boehringer Ingelheim Pharma Gmbh & Co KG			view
JYSB2300166	注射用阿替普酶	alteplase	Lyophilized	Biological Products	Supplementary Application	2023-09-20		Boehringer Ingelheim Pharma Gmbh & Co KG			view
JYSB2300147	注射用阿替普酶	alteplase	Lyophilized	Biological Products	Supplementary Application	2023-08-25		Boehringer Ingelheim Pharma Gmbh & Co KG			view
JYSB2300148	注射用阿替普酶	alteplase	Lyophilized	Biological Products	Supplementary Application	2023-08-25		Boehringer Ingelheim Pharma Gmbh & Co KG			view
JYSB2300093	注射用阿替普酶	alteplase	Lyophilized	Biological Products	Supplementary Application	2023-05-23					view
JYSB2300094	注射用阿替普酶	alteplase	Lyophilized	Biological Products	Supplementary Application	2023-05-23					view
JYSB2200180	注射用阿替普酶	alteplase	Lyophilized	Biological Products	Supplementary Application	2022-09-19		Boehringer Ingelheim Pharma Gmbh & Co KG			view
JYSB2200181	注射用阿替普酶	alteplase	Lyophilized	Biological Products	Supplementary Application	2022-09-19		Boehringer Ingelheim Pharma Gmbh & Co KG			view
JYSB2200161	注射用阿替普酶	alteplase	Lyophilized	Biological Products	Supplementary Application	2022-08-24		Boehringer Ingelheim Pharma Gmbh & Co KG			view
JYSB2200160	注射用阿替普酶	alteplase	Lyophilized	Biological Products	Supplementary Application	2022-08-24		Boehringer Ingelheim Pharma Gmbh & Co KG			view
JYSB2200123	注射用阿替普酶	alteplase	Lyophilized	Biological Products	Supplementary Application	2022-07-11		Boehringer Ingelheim Pharma Gmbh & Co KG			view
JYSB2200122	注射用阿替普酶	alteplase	Lyophilized	Biological Products	Supplementary Application	2022-07-11		Boehringer Ingelheim Pharma Gmbh & Co KG			view
JYSZ2100500	注射用阿替普酶	alteplase	Lyophilized	Biological Products	License Renew	2021-04-01					view
JYSZ2100501	注射用阿替普酶	alteplase	Lyophilized	Biological Products	License Renew	2021-04-01					view
JYSB2000423	注射用阿替普酶	alteplase	Lyophilized	Biological Products	Supplementary Application	2020-08-31	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	Filed	2020-09-11	view
JYSB2000422	注射用阿替普酶	alteplase	Lyophilized	Biological Products	Supplementary Application	2020-08-31	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	Filed	2020-09-11	view